Dopamine Hydrochloride Injection, Solution, Concentrate
Product Images NDC 71872-7066

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dopamine Hydrochloride (NDC 71872-7066). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7066-1.pdp (71872 7066 1)

This is a description for a medication called DOParrine Hydrochloride Injection, which has a concentration of 200mg/5mL. It needs to be diluted before use and contains dopamine hydrochloride, sodium metabisulfite, and other additives to adjust pH levels. It can be used intravenously, needs to be stored at 20-25°C, and requires aseptic techniques for preparation. The medication should only be used if it is clear and not discolored. It is distributed by a company called Scottsdale.*

FDA Label Image

Structural Formula Dopamine (Dopamine 01)

FDA Label Image

Hospira Logo (Dopamine 02)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

This is a description of a Single-dose medication containing Dopamine Hydrochloride USP. Each mL of this medication contains 9 mg of metabisulfite and other components such as citric acid, anhydrous and sodium citrate, dihydrate are added as buffer. The medication must be diluted before Intravenous use. It is distributed by Hospira, Inc, Lake Forest, IL, USA. The text also contains information about the Lot number and expiry date of the medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.